|
| Press Releases |
|
 |
|
| Tuesday, June 7, 2022 |
|
|
Novotech助力Endpoints ASCO 2022年專家組，加速中國腫瘤臨床試驗 |
| Novotech是亞太地區領先的生物技術臨床研究機構，近期入駐美國，助力Endpoints ASCO 2022年專家組，加速中國和美國臨床試驗進程。 more info >> |
|
|
Novotech助力Endpoints ASCO 2022年专家组，加速中国肿瘤临床试验 |
| Novotech是亚太地区领先的生物技术临床研究机构，近期入驻美国，助力Endpoints ASCO 2022年专家组，加速中国和美国临床试验进程。 more info >> |
|
| Monday, June 6, 2022 |
|
|
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 "Accelerating clinical development in China and the US". more info >> |
|
| Friday, June 3, 2022 |
|
|
노보텍, 초기 단계 종양학 임상 및 미-중 규제 전략에 관한 프리-ASCO 중국 서밋의 전문가 패널들을 후원 |
| 최근 미국으로 서비스를 확장한 바 있는 아시아 태평양 지역 바이오테크 전문 임상 시험수탁기관(CRO)인 노보텍(Novotech)은 중국과 미국의 종양학 약물 전문가가 참여하는 2022년 프리-ASCO 중국 서밋의 전문가 패널들을 후원했다. more info >> |
|
|
Novotech 贊助 ASCO 中國峰會前中美早期腫瘤試驗和監管策略專家組 |
| Novotech 是亞太地區領先的生物技術專家 CRO，最近將其服務擴展到美國，在 2022 年 ASCO 前中國峰會上贊助了專家小組，匯集了中國和美國腫瘤藥物開發的領導者。 Pre-ASCO 系列在全球有超過 20,000 人觀看。 more info >> |
|
|
Novotech 赞助 ASCO 中国峰会前中美早期肿瘤试验和监管策略专家组 |
| Novotech 是亚太地区领先的生物技术专家 CRO，最近将其服务扩展到美国，在 2022 年 ASCO 前中国峰会上赞助了专家小组，汇集了中国和美国肿瘤药物开发的领导者。 more info >> |
|
| Thursday, June 2, 2022 |
|
|
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US |
| Novotech, the leading Asia Pacific biotech specialist CRO with recently expanded services to the US, sponsored expert panels at the Pre-ASCO China Summit 2022, bringing together leaders in oncology drug development in China and the US. more info >> |
|
| Thursday, May 12, 2022 |
|
|
노보텍, 프리-ASCO중국 서밋 후원: 초기 단계 종양학 임상에 기반해 진행 여부 결정 |
| 최근 미국으로 서비스를 확장한 바 있는 아시아 태평양 지역 바이오테크 전문 임상시험수탁기관(CRO)인 노보텍(Novotech)은 '초기 단계 종양학 임상에 기반해 진행 여부 결정'이라는 제목의 2022년 프리-ASCO 중국 서밋(이하 '서밋')을 후원하게 된다. more info >> |
|
|
Novotech 贊助 ASCO 中國峰會前夕：基於早期腫瘤學試驗的 Go/No Go 決策 |
| Novotech 是亞太地區領先的生物技術專家 CRO，最近將其 CRO 服務擴展到美國，很高興贊助 2022 年 ASCO 中國峰會前活動，題為：基於早期腫瘤試驗的 Go/No Go Decisions（“峰會”）。 more info >> |
|
|
Novotech 赞助 ASCO 中国峰会前夕：基于早期肿瘤学试验的 Go/No Go 决策 |
| Novotech 是亚太地区领先的生物技术专家 CRO，最近将其 CRO 服务扩展到美国，很高兴赞助 2022 年 ASCO 中国峰会前活动，题为：基于早期肿瘤试验的 Go/No Go Decisions（“峰会”）。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
The Full Spectrum of K-Culture in One Place: "2026 MyK FESTA" to Open June 25
Apr 3, 2026 23:00: JST
|
|
|
The Full Spectrum of K-Culture in One Place: "2026 MyK FESTA" to Open June 25
Apr 3, 2026 23:00 HKT/SGT
|
|
|
HKTDC's response to World Trade Organization's latest report
Apr 3, 2026 23:00 HKT/SGT
|
|
|
海通恒信2025年報：協同效應加速釋放 新興賽道引領結構升級
Apr 3, 2026 20:28 HKT/SGT
|
|
|
海通恒信2025年报：协同效应加速释放 新兴赛道引领结构升级
Apr 3, 2026 19:43 HKT/SGT
|
|
|
HKTDC's response to World Trade Organization's latest report
Apr 3, 2026 17:11: JST
|
|
|
新希望乳業攜手香港十字牌 借道本土老字號共拓港澳市場
Apr 3, 2026 16:51 HKT/SGT
|
|
|
新希望乳业携手香港十字牌 借道本土老字号共拓港澳市场
Apr 3, 2026 16:44 HKT/SGT
|
|
|
新希望乳業與香港十字牌達成戰略合作：雙方充分發揮資源稟賦 助力港澳乳品行業高質量發展
Apr 3, 2026 16:38 HKT/SGT
|
|
|
新希望乳业与香港十字牌达成战略合作：双方充分发挥资源禀赋 助力港澳乳品行业高质量发展
Apr 3, 2026 16:26 HKT/SGT
|
|
|
マツダ、2026年度の参加型モータースポーツ活動計画を発表
Apr 3, 2026 12:00: JST
|
|
|
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
Apr 3, 2026 12:33 JST
|
|
|
Hitachi Rail announces agreement to acquire Clever Devices, marking its growth as a global digital mobility player
Apr 3, 2026 11:09 JST
|
|
|
Datavault AI 執行長納撒尼爾·布拉德利將於 XRP Tokyo 2026 大會上介紹 DataValue(R)、DataScore(R) 及 Information Data Exchange(R) 技術
Apr 3, 2026 07:00 HKT/SGT
|
|
|
Datavault AI 首席执行官纳撒尼尔·布拉德利将在 XRP 东京 2026 大会上介绍 DataValue(R)、DataScore(R) 和 Information Data Exchange(R) 技术
Apr 3, 2026 07:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
